$SSII SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
https://www.globenewswire.com/news-release/20...raine.html
FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine.
SS Innovations International along with RBGM Medical Express Sales Inc., its Manila based distribution partner in the Philippines, is proud to announce the successful registration of the SSi Mantra 3 Surgical Robotic System in the Philippines. The Company believes that this will be a significant step forward in making advanced surgical robotics accessible to Filipino healthcare professionals and institutions. The healthcare market in the Philippines has recently seen rapid growth and now has close to 4,000 hospitals.
Commenting on the receipt of regulatory approval, RBGM President Don Gabriel Oligar T. Cariño III, JD, MBA said, “SS Innovations has started to revolutionize the landscape of robotic surgery by developing cost-effective, high-quality solutions that have brought cutting-edge medical technology to India. With the introduction of the SSi Mantra 3 system to the Philippines, RBGM is committed to bringing the same level of innovation and accessibility to the local medical community.”
“We at RBGM Medical Express Sales Inc. remain steadfast in our mission to deliver state-of-the-art medical technologies that empower healthcare providers, enhance clinical outcomes, and ultimately serve the best interests of the Filipino people. Together, we are excited to embrace the future of surgery—one that is precise, efficient, affordable and accessible to all.”
In addition to receiving the regulatory approval in the Philippines, SS Innovations is also pleased to announce the successful granting of the Certificate of Conformity from the Ukrainian Government to the SSi Mantra 3 through its partnership with Loran Group based out of Kiev, Ukraine. Due to the ongoing conflict, many hospitals and medical facilities have been damaged. Despite these challenges, Ukraine has been actively working to restore its medical infrastructure, which may present a unique opportunity for SS Innovations and its partner, Loran Group, to participate in this rebuilding.
Speaking on behalf of Loran Group, Ms. Roksolana Dmytriv, Head of International Communications and Regulatory Affairs, commented, “Obtaining a certificate of conformity confirms that the equipment meets international quality standards, which is a guarantee of reliability and safety. For medical institutions and doctors, this is critically important, as it ensures that patients receive treatment using reliable and high-quality technologies. Thanks to the successful registration of the SSi Mantra 3 Surgical Robotic System in Ukraine, medical institutions will be able to purchase this high-tech and innovative system to perform complex surgeries with a high level of accuracy and safety. Loran Group is proud to partner with SS Innovations and sees great potential for the future of Ukrainian medicine, especially in the field of robotic technologies that allow doctors to achieve new levels of accuracy and efficiency in treatment.”
Ms. Dmytriv also commented, “The SSI Mantra 3 will enable Ukrainian doctors to perform complex and highly precise surgeries in urology, cardiology, general and thoracic surgery, gynecology, and head and neck surgery. The system will enable doctors to reach a level that has been unattainable for many medical institutions in the country until now. This innovative robotic surgical system will also provide patients with the best results with minimal complications and faster rehabilitation. Loran Group's partnership with SS Innovations opens up new opportunities for the development of the medical industry in Ukraine, raising the level of medical services and improving the health of patients.”
Commenting on these two milestones, SS Innovations President and COO, Dr. Vishwa Srivastava said, “We are extremely grateful for the opportunities provided to be able to offer gold standard care to countries and populations that are often overlooked. It has always been our vision and mission to deliver the latest medical technologies to parts of the world that often have limited access to cost-effective and innovative solutions. By receiving both of these regulatory approvals, we are looking forward to launching SSi Mantra 3 Surgical Robotic Programs in the Philippines and Ukraine, delivering the best possible care to their citizens.”
https://www.globenewswire.com/news-release/20...raine.html
FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine.
SS Innovations International along with RBGM Medical Express Sales Inc., its Manila based distribution partner in the Philippines, is proud to announce the successful registration of the SSi Mantra 3 Surgical Robotic System in the Philippines. The Company believes that this will be a significant step forward in making advanced surgical robotics accessible to Filipino healthcare professionals and institutions. The healthcare market in the Philippines has recently seen rapid growth and now has close to 4,000 hospitals.
Commenting on the receipt of regulatory approval, RBGM President Don Gabriel Oligar T. Cariño III, JD, MBA said, “SS Innovations has started to revolutionize the landscape of robotic surgery by developing cost-effective, high-quality solutions that have brought cutting-edge medical technology to India. With the introduction of the SSi Mantra 3 system to the Philippines, RBGM is committed to bringing the same level of innovation and accessibility to the local medical community.”
“We at RBGM Medical Express Sales Inc. remain steadfast in our mission to deliver state-of-the-art medical technologies that empower healthcare providers, enhance clinical outcomes, and ultimately serve the best interests of the Filipino people. Together, we are excited to embrace the future of surgery—one that is precise, efficient, affordable and accessible to all.”
In addition to receiving the regulatory approval in the Philippines, SS Innovations is also pleased to announce the successful granting of the Certificate of Conformity from the Ukrainian Government to the SSi Mantra 3 through its partnership with Loran Group based out of Kiev, Ukraine. Due to the ongoing conflict, many hospitals and medical facilities have been damaged. Despite these challenges, Ukraine has been actively working to restore its medical infrastructure, which may present a unique opportunity for SS Innovations and its partner, Loran Group, to participate in this rebuilding.
Speaking on behalf of Loran Group, Ms. Roksolana Dmytriv, Head of International Communications and Regulatory Affairs, commented, “Obtaining a certificate of conformity confirms that the equipment meets international quality standards, which is a guarantee of reliability and safety. For medical institutions and doctors, this is critically important, as it ensures that patients receive treatment using reliable and high-quality technologies. Thanks to the successful registration of the SSi Mantra 3 Surgical Robotic System in Ukraine, medical institutions will be able to purchase this high-tech and innovative system to perform complex surgeries with a high level of accuracy and safety. Loran Group is proud to partner with SS Innovations and sees great potential for the future of Ukrainian medicine, especially in the field of robotic technologies that allow doctors to achieve new levels of accuracy and efficiency in treatment.”
Ms. Dmytriv also commented, “The SSI Mantra 3 will enable Ukrainian doctors to perform complex and highly precise surgeries in urology, cardiology, general and thoracic surgery, gynecology, and head and neck surgery. The system will enable doctors to reach a level that has been unattainable for many medical institutions in the country until now. This innovative robotic surgical system will also provide patients with the best results with minimal complications and faster rehabilitation. Loran Group's partnership with SS Innovations opens up new opportunities for the development of the medical industry in Ukraine, raising the level of medical services and improving the health of patients.”
Commenting on these two milestones, SS Innovations President and COO, Dr. Vishwa Srivastava said, “We are extremely grateful for the opportunities provided to be able to offer gold standard care to countries and populations that are often overlooked. It has always been our vision and mission to deliver the latest medical technologies to parts of the world that often have limited access to cost-effective and innovative solutions. By receiving both of these regulatory approvals, we are looking forward to launching SSi Mantra 3 Surgical Robotic Programs in the Philippines and Ukraine, delivering the best possible care to their citizens.”
